Related Experiment Videos
Stress urinary incontinence: new management options.
1Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford, UK. Simon.Jackson@orh.nhs.uk
Current Medical Research and Opinion
|October 22, 2005
Summary
Stress urinary incontinence (SUI) affects many women, but few seek medical help. A new oral medication offers an effective treatment option beyond pelvic floor exercises and surgery for SUI management.
Area of Science:
- Urology
- Pharmacology
Background:
- Stress urinary incontinence (SUI) is the most common type of urinary incontinence.
- SUI significantly impacts quality of life, yet less than a third of UK patients consult a GP.
Purpose of the Study:
- To review current treatments for SUI.
- To evaluate the role of a novel oral agent in SUI management.
Main Methods:
- Literature search using PubMed with keywords 'stress urinary incontinence', 'management', and specific therapies.
- Inclusion of Department of Health guidance and associated UK bodies' recommendations.
Main Results:
- Pelvic floor exercises are the primary conservative treatment for SUI.
- Surgical intervention was previously the only option for treatment-resistant cases.
- A selective serotonin and noradrenaline reuptake inhibitor has shown efficacy in treating SUI.
Conclusions:
- The new oral agent represents a significant advancement in SUI treatment.
- This pharmacological option provides an alternative for patients unresponsive to conservative measures.
- This review profiles current SUI treatments and the emerging role of oral agents.